SGTI Stock Overview
Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Shengtai Pharmaceutical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.000001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SGTI | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | 2.0% |
| 1Y | n/a | 13.7% | 32.4% |
Return vs Industry: Insufficient data to determine how SGTI performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SGTI performed against the US Market.
Price Volatility
| SGTI volatility | |
|---|---|
| SGTI Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SGTI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SGTI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Qingtai Liu | n/a |
Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People’s Republic of China and internationally. The company provides pharmaceutical and medical grade products, including dextrose monohydrate, dextrose anhydrous, dextrin, and pharmaceutical grade cornstarch; and rough glucose, dextrose monohydrate oral, and food and beverage grade cornstarch for the food and beverage, and processing industries. It also offers other products comprising fibers, corn embryo, protein powder, mother liquid, and abamectin ointment.
Shengtai Pharmaceutical, Inc. Fundamentals Summary
| SGTI fundamental statistics | |
|---|---|
| Market cap | US$9.00 |
| Earnings (TTM) | -US$1.55m |
| Revenue (TTM) | US$221.39m |
0.0x
P/S Ratio0.0x
P/E RatioIs SGTI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SGTI income statement (TTM) | |
|---|---|
| Revenue | US$221.39m |
| Cost of Revenue | US$202.46m |
| Gross Profit | US$18.92m |
| Other Expenses | US$20.47m |
| Earnings | -US$1.55m |
Last Reported Earnings
Jun 30, 2014
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SGTI perform over the long term?
See historical performance and comparison